Lerner Lorena Raquel
SEC CIK 2081359 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | CSO | 27.6K | — | $100.0K | 2 | 2026-02-18 | 2026-08-18 |
Most active insiders at KROS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schneeberger Daniel | 10% | — | $95.66M |
| 2 | Pontifax (China) IV L.P. | 10% | — | $84.98M |
| 3 | Cho Esther | SVP, GC | — | $123.7K |
| 4 | Seehra Jasbir | CEO, Dir | — | $113.4K |
| 5 | Lerner Lorena Raquel | CSO | — | $100.0K |
| 6 | Regnante Keith | CFO | — | $77.5K |
| 7 | BIENAIME JEAN JACQUES | Dir | $75.8K | — |
| 8 | Knowles Julius | Dir | — | $28.2K |
| 9 | Farzan Nima | Dir | — | $28.2K |
| 10 | Seth Alpna | Dir | — | $28.1K |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 16:10 | 2026-08-18 | KROS | Keros Therapeutics, Inc. | Lerner Lorena Raquel | CSO | S - Sale | $10.29 | -3,568 | 27.6K | -11% | -$36.7K | |
| 2026-02-20 | 2026-02-18 | KROS | Keros Therapeutics, Inc. | Lerner Lorena Raquel | CSO | S - Sale | $16.35 | -3,873 | 31.1K | -11% | -$63.3K |
Purchase Sale Sale after option exercise All abbreviations